Therapy for Children With Advanced Stage Neuroblastoma
Phase 2 Completed
153 enrolled 12 charts
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
Phase 2 Completed
92 enrolled
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Phase 2 Completed
344 enrolled 11 charts
TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 2 Completed
47 enrolled
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
Phase 2 Completed
101 enrolled 19 charts
ATEZOLACC
Phase 2 Completed
189 enrolled
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Phase 2 Completed
28 enrolled
Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients
Phase 2 Completed
100 enrolled
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Phase 2 Completed
39 enrolled 16 charts
DARTBOARD
Phase 2 Completed
50 enrolled
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
Phase 2 Completed
26 enrolled 6 charts
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
Phase 2 Completed
106 enrolled 12 charts
Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Phase 2 Completed
41 enrolled 9 charts
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer
Phase 2 Completed
121 enrolled 25 charts
MesoPDT
Phase 2 Completed
6 enrolled
CheckMate 6DW
Phase 2 Completed
102 enrolled
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Phase 2 Completed
67 enrolled 15 charts
LyMa101
Phase 2 Completed
86 enrolled
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
Phase 2 Completed
40 enrolled 14 charts
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Phase 2 Completed
34 enrolled 12 charts
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 2 Completed
60 enrolled
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
20 enrolled 20 charts
CETUXICOL
Phase 2 Completed
76 enrolled
PINBALL
Phase 2 Completed
27 enrolled
CUPISCO
Phase 2 Completed
529 enrolled 16 charts
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
Phase 2 Completed
76 enrolled 10 charts
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
Phase 2 Completed
316 enrolled 31 charts
A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC
Phase 2 Completed
65 enrolled
AACER
Phase 2 Completed
53 enrolled
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
Phase 2 Completed
147 enrolled 15 charts
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Completed
17 enrolled 12 charts
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
272 enrolled 17 charts
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
TPFmORL
Phase 2 Completed
105 enrolled
PPIO-004-EC001
Phase 2 Completed
118 enrolled
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Phase 2 Completed
30 enrolled 13 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Phase 2 Completed
57 enrolled
ECHO-07
Phase 2 Completed
42 enrolled 24 charts
INNOVATION
Phase 2 Completed
172 enrolled
Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC
Phase 2 Completed
81 enrolled
ECWHCCFLACC
Phase 2 Completed
120 enrolled
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Phase 2 Completed
52 enrolled
KEYNOTE-B99
Phase 2 Completed
126 enrolled
PLATINUM
Phase 2 Completed
152 enrolled
Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer
Phase 2 Completed
227 enrolled
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
Phase 2 Completed
9 enrolled
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
Phase 2 Completed
94 enrolled 16 charts
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 2 Completed
160 enrolled 12 charts